ANNOUNCEMENT
Action B – “Competitiveness 2021-2027” Programme
Exhaustion of the annual aid ceiling and continuation of the evaluation of CRGR-FTV investment projects
Date: 16.09.2026
The annual ceiling for the granting of aid under Action B of the “Competitiveness 2021-2027” Programme (NSRF), which has been set at fifty-five million euros (€55,000,000) per year and is calculated at the level of inclusion decisions, has been exhausted for the current year.
In view of the above, EKKOMED hereby informs all interested parties that:
1. The submission of applications and the evaluation of the investment projects that have been or will be submitted under the regime of Action B of the Cash Rebate Greece – FTV (CRGR-FTV) programme, for the support of the production of audiovisual works in the field of cinema and television programmes in Greece, shall continue without interruption until the total available budget is exhausted.
2. The results of the evaluation shall be notified to the beneficiaries through the issuance of an enhanced Letter of Intent (LoI), which may be used for any lawful purpose, including the assignment of the aid to a financial institution. The aforementioned letter reflects the outcome of the evaluation and does not substitute the inclusion decision, which is issued in accordance with the provisions of the immediately following paragraph.
3. The decisions approving the evaluation results and the decisions on the inclusion of the investment plans in the co-financed “Competitiveness” Programme shall be issued as from 1 January 2027.
***
EKKOMED remains committed to safeguarding the continuity, the transparency and the predictability of the Cash Rebate Greece (CRGR) Programme, supporting the strategic planning of producers and the financing certainty of investment plans.
For further information or technical clarifications, interested parties are kindly requested to contact the Directorate-General for Investments and Innovation in Audiovisual Creation of EKKOMED, as well as the e-mail address dirinvest@ekkomed.gr.